F Gozzelino

704 total citations
9 papers, 591 citations indexed

About

F Gozzelino is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, F Gozzelino has authored 9 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in F Gozzelino's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer therapeutics and mechanisms (3 papers). F Gozzelino is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer therapeutics and mechanisms (3 papers). F Gozzelino collaborates with scholars based in Italy, Netherlands and Belgium. F Gozzelino's co-authors include Giorgio V. Scagliotti, Monica Rinaldi, Maurizio Tonato, Lucio Crinò, M. Marangolo, Filippo de Marinis, Vincenzo Adamo, A Masotti, L Portalone and Francesco Di Costanzo and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and European Respiratory Journal.

In The Last Decade

F Gozzelino

9 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Gozzelino Italy	7	433	406	216	81	78	9	591
Hisao Uejima Japan	11	371 0.9×	374 0.9×	127 0.6×	35 0.4×	35 0.4×	22	549
Minsig Choi United States	14	360 0.8×	134 0.3×	190 0.9×	104 1.3×	60 0.8×	28	549
Alberto Cambieri Italy	6	470 1.1×	512 1.3×	336 1.6×	195 2.4×	45 0.6×	6	790
M.P. López-Cabrerizo Spain	7	404 0.9×	414 1.0×	144 0.7×	105 1.3×	23 0.3×	8	577
F. Gamza United States	4	979 2.3×	1.0k 2.5×	216 1.0×	94 1.2×	19 0.2×	5	1.2k
P. Dieringer United States	7	203 0.5×	158 0.4×	299 1.4×	76 0.9×	24 0.3×	10	501
N Masuda Japan	12	263 0.6×	107 0.3×	347 1.6×	109 1.3×	82 1.1×	18	588
Ryoichi Onozato Japan	5	425 1.0×	555 1.4×	226 1.0×	121 1.5×	16 0.2×	8	678
Roxana Azimi United States	3	347 0.8×	112 0.3×	167 0.8×	74 0.9×	44 0.6×	7	501
D. Ilegbodu United States	12	574 1.3×	181 0.4×	105 0.5×	162 2.0×	26 0.3×	30	711

Countries citing papers authored by F Gozzelino

Since Specialization

Citations

This map shows the geographic impact of F Gozzelino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Gozzelino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Gozzelino more than expected).

Fields of papers citing papers by F Gozzelino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Gozzelino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Gozzelino. The network helps show where F Gozzelino may publish in the future.

Co-authorship network of co-authors of F Gozzelino

This figure shows the co-authorship network connecting the top 25 collaborators of F Gozzelino. A scholar is included among the top collaborators of F Gozzelino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Gozzelino. F Gozzelino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Rosell, Rafael, Giorgio V. Scagliotti, Kathleen D. Danenberg, et al.. (2003). Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer. Oncogene. 22(23). 3548–3553. 164 indexed citations

2.

Crinò, Lucio, Giorgio V. Scagliotti, Serafino Ricci, et al.. (1999). Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project. Journal of Clinical Oncology. 17(11). 3522–3530. 302 indexed citations

3.

Postmus, Pieter E., Giorgio V. Scagliotti, Harry J.M. Groen, et al.. (1996). Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial. European Journal of Cancer. 32(9). 1498–1503. 24 indexed citations

4.

Jassem, Jacek, H Karnicka-Młodkowska, C van Pottelsberghe, et al.. (1993). Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. European Journal of Cancer. 29(12). 1720–1722. 65 indexed citations

5.

Scagliotti, Giorgio V., et al.. (1989). Chronic Administration of Lonidamine in Untreated Non-Small Cell Lung Cancer of Stage III M<sub>0–1</sub>. Chemotherapy. 35(1). 64–68. 13 indexed citations

6.

Gozzelino, F, et al.. (1989). Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer. European Respiratory Journal. 2(8). 746–750. 13 indexed citations

7.

Scagliotti, Giorgio V., et al.. (1985). Unresectable Non-Small Cell Lung Cancer Chemotherapy with High-Dose Cisplatin and Etoposide. Oncology. 42(4). 224–228. 8 indexed citations

8.

Scagliotti, Giorgio V., et al.. (1984). Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.. PubMed. 3(5). 324–6. 1 indexed citations

9.

Gozzelino, F, et al.. (1980). [Respiratory pathology caused by Mycoplasma pneumoniae].. PubMed. 71(49). 3639–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact